These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 31997506)
1. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway. Zhang S; Li C; Liu J; Geng F; Shi X; Li Q; Lu Z; Pan Y FEBS J; 2020 Sep; 287(18):4032-4047. PubMed ID: 31997506 [TBL] [Abstract][Full Text] [Related]
2. Resveratrol is an inhibitory polyphenol of epithelial-mesenchymal transition induced by Fusobacterium nucleatum. Min J; Mashimo C; Nambu T; Maruyama H; Takigawa H; Okinaga T Arch Oral Biol; 2024 Apr; 160():105897. PubMed ID: 38290225 [TBL] [Abstract][Full Text] [Related]
3. Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells. Shao W; Fujiwara N; Mouri Y; Kisoda S; Yoshida K; Yoshida K; Yumoto H; Ozaki K; Ishimaru N; Kudo Y Sci Rep; 2021 Jul; 11(1):14943. PubMed ID: 34294795 [TBL] [Abstract][Full Text] [Related]
4. Human Primary Epithelial Cells Acquire an Epithelial-Mesenchymal-Transition Phenotype during Long-Term Infection by the Oral Opportunistic Pathogen, Lee J; Roberts JS; Atanasova KR; Chowdhury N; Han K; Yilmaz Ö Front Cell Infect Microbiol; 2017; 7():493. PubMed ID: 29250491 [No Abstract] [Full Text] [Related]
5. Analysis of differentially expressed genes in oral epithelial cells infected with Fusobacterium nucleatum for revealing genes associated with oral cancer. Zhang S; Li C; Zhang Z; Li Y; Li Q; Geng F; Liu J; Pan Y J Cell Mol Med; 2021 Jan; 25(2):892-904. PubMed ID: 33289330 [TBL] [Abstract][Full Text] [Related]
6. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway. Zhang H; Sun JD; Yan LJ; Zhao XP Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215 [TBL] [Abstract][Full Text] [Related]
7. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1. Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483 [TBL] [Abstract][Full Text] [Related]
8. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis. Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715 [TBL] [Abstract][Full Text] [Related]
9. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells. Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461 [TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition in oral cancer cells induced by prolonged and persistent Fusobacterium nucleatum stimulation. Nakano S; Kasai M; Nakamura K; Akasaka T; Yoshida Y; Suzuki S; Ohiro Y; Hasebe A J Oral Biosci; 2024 Sep; 66(3):594-604. PubMed ID: 38782256 [TBL] [Abstract][Full Text] [Related]
11. Geng F; Zhang Y; Lu Z; Zhang S; Pan Y DNA Cell Biol; 2020 Jan; 39(1):144-151. PubMed ID: 31765243 [TBL] [Abstract][Full Text] [Related]
12. LncRNA GAS5 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition in oral squamous cell carcinoma by regulating the miR-21/PTEN axis. Zeng B; Li Y; Jiang F; Wei C; Chen G; Zhang W; Zhao W; Yu D Exp Cell Res; 2019 Jan; 374(2):365-373. PubMed ID: 30576678 [TBL] [Abstract][Full Text] [Related]
13. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p. Han L; Cheng J; Li A Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508 [No Abstract] [Full Text] [Related]
15. F. Nucleatum enhances oral squamous cell carcinoma proliferation via E-cadherin/β-Catenin pathway. Li Z; Liu Y; Huang X; Wang Q; Fu R; Wen X; Liu J; Zhang L BMC Oral Health; 2024 May; 24(1):518. PubMed ID: 38698370 [TBL] [Abstract][Full Text] [Related]
16. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum. Despins CA; Brown SD; Robinson AV; Mungall AJ; Allen-Vercoe E; Holt RA mBio; 2021 Oct; 12(5):e0206221. PubMed ID: 34700376 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells. Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631 [TBL] [Abstract][Full Text] [Related]
18. SNAI1 Promotes the Cholangiocellular Phenotype, but not Epithelial-Mesenchymal Transition, in a Murine Hepatocellular Carcinoma Model. Xu M; Wang J; Xu Z; Li R; Wang P; Shang R; Cigliano A; Ribback S; Solinas A; Pes GM; Evert K; Wang H; Song X; Zhang S; Che L; Pascale RM; Calvisi DF; Liu Q; Chen X Cancer Res; 2019 Nov; 79(21):5563-5574. PubMed ID: 31383647 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis. Gao LF; Li W; Liu YG; Zhang C; Gao WN; Wang L Front Oncol; 2021; 11():661288. PubMed ID: 34532282 [TBL] [Abstract][Full Text] [Related]
20. The effect and mechanism of miR-30e-5p targeting SNAI1 to regulate epithelial-mesenchymal transition on pancreatic cancer. Liang Z; Tang S; He R; Luo W; Qin S; Jiang H Bioengineered; 2022 Apr; 13(4):8013-8028. PubMed ID: 35300562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]